The Center for AIDS Research is directed by Douglas D. Richman, MD, who reports directly to the Dean of the School of Medicine. The management of the Center is assisted by its Executive Committee and External Advisory Committee. The Executive Committee consists of Dennis Burton, PhD, of The Scripps Research Institute (TSRI);Nathaniel Landau, PhD, of the Salk Institute;Carl Ware, PhD, of the La Jolla Institute for Allergy and Immunology (LJIAI);and UCSD faculty members, Constance Benson, MD;Igor Grant, MD;J. Allen McCutchan, MD, MSc;and Joshua Fierer, MD. Bruce Torbett, PhD, MSPH, of TSRI has served on the Executive Committee since its creation;however, with the new Protein Expression and Proteomics Core, which he will co-direct, Dr. Burton has agreed to represent TSRI on the Executive Committee in his stead. The External Advisory Board members include Ronald Desrosiers, PhD, New England Regional Primate Research Center, Harvard Medical School;David Ho, MD, Aaron Diamond AIDS Research Center, Rockefeller University;King Holmes, MD, PhD, Harborview Medical Center, University of Washington;Eric Hunter, PhD, Emory University Vaccine Research Center;Gary Nabel, Vaccine Research Center, NIAID/NIH;and Mario Stevenson, PhD, University of Massachusetts Medical School. The Administrative Core organizes and maintains the policies and procedures of the CFAR as a whole, thereby ensuring the efficient operation and management of the Center. To support an effective Center, the Core maintains close ties with University officials, specifically the Office of Contracts and Grants and the Dean's office. Because the CFAR is a multidisciplinary center, the Core collaborates closely with the UCSD Antiviral Research Center, the Owen Clinic, and the HIV Neurobehavioral Research Center, and participates in outreach and educational activities. With the cooperation and support of the Directors, the Administrator, and the support staff, this Core aims to build an efficient infrastructure to streamline policies and procedures for long-term operations. Specifically, the Core will (1) manage the administration of funding to Cores and activities, monitoring any changes in funding levels;(2) organize and sponsor activities such as the monthly CFAR Seminar Series and the CFAR Community Forum;(3) create and maintain the CFAR website;(4) publish the online newsletter;and (5) establish a visible presence in the San Diego community. The Core also generates annual reports to the appropriate officials, facilitates regular meetings of the Executive Committee and the External Advisory Committee, and ensures open lines of communication and collaboration among all CFAR Cores and members.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI036214-18
Application #
8279324
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
2013-03-31
Budget Start
2011-06-01
Budget End
2013-05-31
Support Year
18
Fiscal Year
2011
Total Cost
$408,682
Indirect Cost
Name
University of California San Diego
Department
Type
DUNS #
804355790
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Giamouridis, Dimosthenis; Gao, Mei Hua; Lai, N Chin et al. (2018) Effects of Urocortin 2 Versus Urocortin 3 Gene Transfer on Left Ventricular Function and Glucose Disposal. JACC Basic Transl Sci 3:249-264
Jenks, Jeffrey D; Reed, Sharon L; Seidel, Danila et al. (2018) Rare mould infections caused by Mucorales, Lomentospora prolificans and Fusarium, in San Diego, CA: the role of antifungal combination therapy. Int J Antimicrob Agents 52:706-712
Drumright, Lydia N; Weir, Sharon S; Frost, Simon D W (2018) The role of venues in structuring HIV, sexually transmitted infections, and risk networks among men who have sex with men. BMC Public Health 18:225
Francesconi, Walter; Berton, Fulvia; Marcondes, Maria Cecilia G (2018) HIV-1 Tat alters neuronal intrinsic excitability. BMC Res Notes 11:275
Lin, Timothy C; Gianella, Sara; Tenenbaum, Tara et al. (2018) A Simple Symptom Score for Acute Human Immunodeficiency Virus Infection in a San Diego Community-Based Screening Program. Clin Infect Dis 67:105-111
Saag, Michael S; Günthard, Huldrych F; Smith, Davey M (2018) Baseline Genotype Testing to Assess Drug Resistance Before Beginning HIV Treatment-Reply. JAMA 320:2154
Howe, Chanelle J; Dulin-Keita, Akilah; Cole, Stephen R et al. (2018) Evaluating the Population Impact on Racial/Ethnic Disparities in HIV in Adulthood of Intervening on Specific Targets: A Conceptual and Methodological Framework. Am J Epidemiol 187:316-325
Arredondo, J; Gaines, T; Manian, S et al. (2018) The law on the streets: Evaluating the impact of Mexico's drug decriminalization reform on drug possession arrests in Tijuana, Mexico. Int J Drug Policy 54:1-8
Hoenigl, Martin; Orasch, Thomas; Faserl, Klaus et al. (2018) Triacetylfusarinine C: A urine biomarker for diagnosis of invasive aspergillosis. J Infect :
Moore, David J; Jain, Sonia; Dubé, Michael P et al. (2018) Randomized Controlled Trial of Daily Text Messages to Support Adherence to Preexposure Prophylaxis in Individuals at Risk for Human Immunodeficiency Virus: The TAPIR Study. Clin Infect Dis 66:1566-1572

Showing the most recent 10 out of 921 publications